Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency T Le Voyer, AV Parent, X Liu, A Cederholm, A Gervais, J Rosain, ... Nature 623 (7988), 803-813, 2023 | 28 | 2023 |
The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants M Materna, OM Delmonte, M Bosticardo, M Momenilandi, PE Conrey, ... Science 383 (6686), eadh4059, 2024 | 3 | 2024 |
Impaired thymic AIRE expression underlies autoantibodies against type I IFNs in humans with inborn errors of the alternative NF-kB pathway T Le Voyer, A Gervais, J Rosain, A Parent, A Cederholm, D Rinchai, ... Authorea Preprints, 2023 | 3 | 2023 |
FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice M Momenilandi, R Lévy, S Sobrino, J Li, C Lagresle-Peyrou, ... Cell 187 (11), 2817-2837. e31, 2024 | 2 | 2024 |
Impaired thymic AIRE expression underlies autoantibodies against type I IFNs in humans with inborn errors of the alternative NF-kB pathway TL Voyer, A Gervais, J Rosain, A Parent, A Cederholm, D Rinchai, ... | 2 | 2023 |
No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines A Yalcinkaya, M Cavalli, A Cederholm, M Aranda-Guillén, A Behere, ... npj Vaccines 9 (1), 42, 2024 | 1 | 2024 |
Impaired thymic AIRE expression underlies autoantibodies against type I IFNs in humans with inborn errors of the alternative NF-κB pathway T Voyer, A Gervais, J Rosain, A Parent, A Cederholm, C Roifman, ... Clinical Immunology (Orlando, Fla.) 250, 109369-109369, 2023 | 1 | 2023 |
Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals JN Peel, R Yang, T Le Voyer, A Gervais, J Rosain, P Bastard, A Behere, ... The Journal of clinical investigation 134 (8), 2024 | | 2024 |
Rare neutralizing IFN-γ autoantibodies in HLA-DRB1* 15: 02 or 16: 02 individuals confer susceptibility to mycobacterial infections. JN Peel, R Yang, T Le Voyer, A Gervais, J Rosain, P Bastard, A Behere, ... The Journal of Clinical Investigation, e178263-e178263, 2024 | | 2024 |